2nd Tumor Myeloid-Directed Therapies Summit
Evvnt Promotion / evvnt
Archivo
14.06.2022 - 16.06.2022 Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, USA
Time: 8:00 AM - 6:00 PM
Temas de la conferencia
Returning in 2022, the Tumor Myeloid-Directed Therapeutics Summit is the only industry-focused meeting dedicated to unlocking novel therapeutic potential through the myeloid compartment.
This is your ultimate forum to identify, validate, and clinically progress myeloid targets to expand the oncologists toolkit and realize better responses by engaging myeloid anti-tumor function.
Returning in 2022, the Tumor Myeloid-Directed Therapeutics Summit is the only industry-focused meeting dedicated to unlocking novel therapeutic potential through the myeloid compartment.
This is your ultimate forum to identify, validate, and clinically progress myeloid targets to expand the oncologists toolkit and realize better responses by engaging myeloid anti-tumor function.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Información e inscripción:
https://go.evvnt.com/1007623-1?pid=4832
Ms. Hollie Bulfin
Oncología
Idioma
Inglés
Inglés
Cuota del Congreso
USD 2199.00 - USD 4846.00
USD 2199.00 - USD 4846.00
Los participantes esperaban
1000
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
